2017至2021年美国毒物中心报告的儿童手消毒剂暴露
研究基于美国国家毒物数据系统,纳入2017年1月1日至2021年12月31日≤19岁儿童单物质醇类手消毒剂暴露病例,以及2020年6月23日至2021年12月31日含甲醇手消毒剂病例。共95,718例醇类手消毒剂病例,多数为无意暴露(94%)、经口摄入(93.9%)、在家发生(93.8%在暴露现场处理);常见症状为呕吐3.1%、咳嗽1.2%、眼部刺激1.3%、嗜睡1.0%。在医疗机构处理的儿童中66.2%治疗后离院,9.0%住院,1.4%入住ICU;2020和2021年临床显著病例的患病率较2017年增加。含甲醇手消毒剂报告540例,多数(255例)发生在2020年7月,13例(2.4%)有临床显著结局,其患病率在2020和2021年相似且低于醇类产品。
要点
- 2017至2021年共95,718例≤19岁儿童醇类手消毒剂暴露,94%为无意暴露,93.9%为经口摄入,93.8%在暴露现场处理。
- 在医疗机构处理的儿童中66.2%治疗后离院,9.0%住院,1.4%入住ICU。
- 常见症状为呕吐3.1%、咳嗽1.2%、眼部刺激1.3%、嗜睡1.0%。
- 2020和2021年临床显著病例(中度或重度效应或死亡)的患病率较2017年增加,2021年仍居高不下。
- 含甲醇手消毒剂报告540例,多数(255例)发生在2020年7月,13例(2.4%)有临床显著结局,其患病率低于醇类产品。
适用人群与场景
- ≤19岁儿童单物质醇类手消毒剂暴露病例,报告至美国国家毒物数据系统,2017年1月1日至2021年12月31日。
- 含甲醇手消毒剂暴露病例,2020年6月23日至2021年12月31日。
- 排除多次产品暴露和非人类暴露。
研究设计与关键结果
- 研究类型为基于美国国家毒物数据系统的回顾性分析,纳入95,718例醇类手消毒剂儿童病例。
- 多数为无意暴露(n=89,521;94%)、经口摄入(n=89,879;93.9%)、在家发生,并在暴露现场处理(n=89,774;93.8%)。
- 常见症状:呕吐(n=2,969;3.1%)、咳嗽(n=1,102;1.2%)、眼部刺激(n=1,244;1.3%)、嗜睡(n=981;1.0%)。
- 在医疗机构处理的儿童中,治疗后离院n=3,937(66.2%),住院n=527(9.0%),入住ICU n=81(1.4%)。
- 2020和2021年临床显著病例的患病率较2017年增加。
- 按州人口调整的醇类手消毒剂病例率范围为每百万儿童280至2,700例。
- 含甲醇手消毒剂报告540例,多数(n=255)发生在2020年7月;13例(2.4%)有临床显著结局;2020和2021年临床显著病例患病率相似,且低于醇类产品;按州人口调整的病例率范围为每百万儿童少于0.9至40例。
证据类型、等级与局限
- 证据类型:基于美国国家毒物数据系统的回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,本研究发现可能有助于加强产品质量控制和监管监督。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The COVID-19 pandemic increased demand for alcohol-based hand sanitizers. We aimed to describe the epidemiological trends in pediatric alcohol-based hand sanitizer cases reported to United States poison centers. We characterized clinically significant pediatric reports involving alcohol-based hand sanitizer products before and during the pandemic and methanol-containing hand sanitizers during the pandemic.
METHODS: We included all single-substance cases involving alcohol-based hand sanitizers reported to the National Poison Data System among children ≤ 19 years from 1 January 2017 to 31 December 2021, and methanol-containing hand sanitizers from 23 June 2020 to 31 December 2021. Multiple product exposures and non-human exposures were excluded. Clinically significant outcomes included moderate or major effects or death.
RESULTS: There were 95,718 alcohol-based hand sanitizer pediatric cases during the study period. Most (n = 89,521; 94%) were unintentional, occurred by ingestion (n = 89,879; 93.9%), occurred at home, and were managed at the exposure site (n = 89,774; 93.8%). Common symptoms were vomiting (n = 2,969; 3.1%), coughing (n = 1,102; 1.2%), ocular irritation (n = 1,244; 1.3%), and drowsiness (n = 981; 1.0%). Most children (n = 3,937; 66.2%) managed at a health care facility were treated and released; a minority were admitted (n = 527; 9.0%). Few children (n = 81; 1.4%) were admitted to the intensive care unit. The prevalence of clinically significant cases increased in 2020 and 2021, compared to 2017. Population-adjusted rates, by state, of alcohol-based hand sanitizer cases ranged from 280 to 2,700 per million children. Of the 540 reported cases involving methanol-containing hand sanitizers, the majority (n = 255) occurred in July 2020. Thirteen cases (2.4%) had clinically significant outcomes. The prevalence of clinically significant cases remained similar in 2020 and 2021 and exhibited lower prevalence compared to alcohol-based products. Population-adjusted rates, by state, ranged from fewer than 0.9 to 40 per million children.
CONCLUSIONS: Clinically significant pediatric cases involving alcohol-based hand sanitizers increased during the pandemic and remained elevated in 2021. Cases involving methanol-containing products were less frequent. Our findings may inform heightened product quality control and regulatory oversight.
参考来源
- Vohra V, Lelak K, Neuman MI, et al. Pediatric hand sanitizer exposures reported to United States poison centers, 2017-2021. Clin Toxicol (Phila). 2023. PMID: 37358035. doi:10.1080/15563650.2023.2221816
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。